IMICIL

This brand name is authorized in Brazil, Ecuador, Turkey

Active ingredients

The drug IMICIL contains a combination of these active pharmaceutical ingredients (APIs):

1 Imipenem monohydrate UNII 71OTZ9ZE0A - IMIPENEM

Imipenem is a semi-synthetic derivative of thienamycin, the parent compound produced by the filamentous bacterium Streptomyces cattleya. Imipenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs). Read about Imipemide

2 Cilastatin UNII 5428WXZ74M - CILASTATIN SODIUM

Read about Cilastatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DH51	Imipenem and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 533023501152412
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1857-MEE-0316
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699844262297